SCHEMBL7035012

SCHEMBL7035012

Cc1cc(C)c(C(=O)c2ccc(N)cc2Cl)cc1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.48
JAK2 O60674 1/20 0.43
TYK2 P29597 1/20 0.43
MAPK13 O15264 5/20 0.43
MAPK12 P53778 5/20 0.43
MAPK11 Q15759 5/20 0.43
MAPK14 Q16539 5/20 0.43
CHRM2 P08172 1/20 0.43
CHRM3 P20309 1/20 0.43
MAOA P21397 1/20 0.43
HTR2C P28335 1/20 0.43
CHRNA4 P43681 1/20 0.43
HTR3A P46098 1/20 0.43
KCNH2 Q12809 1/20 0.43
HRH3 Q9Y5N1 1/20 0.43
NPC1 O15118 1/20 0.41
MITF O75030 1/20 0.41
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.41
CA1 P00915 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12424014 0.86 ALDH1A1 (0.50) CYP3A4MAPK13MAPK12MAPK11MAPK14
SCHEMBL7090488 0.86 JAK2 (0.53) CYP3A4JAK2TYK2CHRM2CHRM3
SCHEMBL5174662 0.85 RAB9A (0.48) CYP3A4JAK2TYK2MAPK13MAPK12
SCHEMBL5174489 0.84 CYP3A4 (0.50) CYP3A4JAK2TYK2MAPK13MAPK12
SCHEMBL2198191 0.83 SRD5A2 (0.47) CYP3A4JAK2TYK2MAPK13MAPK12
SCHEMBL5174799 0.83 MAPK14 (0.53) CYP3A4JAK2TYK2MAPK13MAPK12
SCHEMBL5172393 0.82 MAPK13 (0.61) CYP3A4MAPK13MAPK12MAPK11MAPK14
SCHEMBL2199850 0.81 MAPK13 (0.52) CYP3A4JAK2TYK2MAPK13MAPK12
Acetic Acid SCHEMBL2199665 0.80 SRD5A2 (0.47) CYP3A4JAK2TYK2MAPK13MAPK12
SCHEMBL5172405 0.80 RAB9A (0.54) CYP3A4JAK2TYK2MAPK13MAPK12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1289958-A2 BENZOPHENONES AS INHIBITORS OF IL-1$g(b) AND TNF-$g(a) Leo Pharma A/S (DK) 2003-03-12 EP disclosed
US-6432962-B2 Benzophenones as inhibitors of IL-1β and TNF-α LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2002-08-13 US disclosed
US-20020016347-A1 Benzophenones as inhibitors of IL-1beta and TNF-alpha LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2002-02-07 US disclosed
WO-2001090074-A2 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) LEO PHARMA A/S (DK) 2001-11-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020016347-A1 Benzophenones as inhibitors of IL-1beta and TNF-alpha IL1B, IL1A, NFKBIA CYP3A4 1015/4885JAK2 414/4885TYK2 977/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.